semaglutide patent expiry 2031 Overpatented 2025 – I-MAK Magic pill' moment? What happens

In a pivotal year-long trial, individuals undergoing semaglutide treatment experienced an average weight loss of 14.9%, with approximately one-third achieving an impressive weight reduction exceeding 20% (PubMed)

Comparative Weight Loss Efficacy The landmark trials for both drugs show them operating in the realm previously reserved for bariatric surgery

The presence of multiple cardiovascular risk factors strengthens the indication for pharmacotherapy-assisted weight management

Fat Loss Patterns Men lose proportionally more visceral fat (around internal organs), while women lose proportionally more subcutaneous fat (under the skin)

Town of Redding, Connecticut Official Website

Patients should start very slowly so that their bodies can adjust appropriately to the new regimen, and better outcomes might follow eventually